Have a question? Book your consultation on WhatsApp — we reply in minutes.

Book on WhatsApp
Weight Loss Clinic Bangkok — Doctor-Led GLP-1
موصى به من الطبيب
Medical Weight Loss Hub

Weight Loss Clinic Bangkok — Doctor-Led GLP-1

Feel Better. Live Longer. · Healthi Life, Ekkamai 10 Bangkok

Doctor-led medical weight loss at Healthi Life Ekkamai. Three physician-supervised GLP-1 options — Mounjaro, Wegovy and Retatrutide — selected on the basis of your medical history, contraindications and baseline biomarkers. Prescription only.

يبدأ منFrom ฿10,000

Per vial — full program confirmed at physician consultation

Physician-Supervised
Biomarker-Monitored
Prescription Only
Ekkamai, Bangkok

ما الذي ستحصل عليه

Physician consultation and contraindication review
Baseline and follow-up biomarker monitoring
Personalized GLP-1 selection and titration plan
لماذا تختار هذا العلاج

Why a Doctor-Led GLP-1 Program

Doctor-Led, Not Cosmetic

Programs initiated by a licensed physician after full medical intake and contraindication screening.

Three GLP-1 Options

Mounjaro (dual GIP/GLP-1), Wegovy (GLP-1), Retatrutide (investigational triple agonist) — matched to your profile.

Biomarker-Monitored

Baseline and follow-up labs (HbA1c, lipids, hepatic, renal) frame every dose adjustment.

Contraindication Review

MTC, MEN-2, pancreatitis and pregnancy screening before any prescription.

Injection Training

Weekly subcutaneous self-injection taught in clinic, with adherence support.

Longevity Integration

Integrated with hormone, metabolic and biomarker programs for long-term outcomes.

هل هذا مناسب لك؟

مثالي لـ

  • Adults with BMI ≥ 30, or ≥ 27 with a weight-related comorbidity
  • Guests who have not reached goals with diet and lifestyle alone
  • Candidates committed to monthly follow-up and biomarker review
  • Expats and international visitors — start in-clinic, continue by telemedicine

غير موصى به لـ

  • Pregnant, planning pregnancy, or breastfeeding women
  • Personal or family history of medullary thyroid carcinoma (MTC) or MEN-2
  • History of pancreatitis or severe gastrointestinal disease
رحلتك العلاجية

Our 4-Step Medical Weight Loss Process

1

Physician Consultation

Full medical history, medication review and goal-setting with the physician.

2

Baseline Biomarkers

HbA1c, lipid panel, hepatic and renal function established before any prescription.

3

Molecule Selection

The physician selects Mounjaro, Wegovy or Retatrutide based on your profile and contraindications.

4

Monthly Follow-Up

Clinical review, side-effect assessment and dose adjustment every four weeks.

التميز الطبي

لماذا تثق بـ Healthi Life

بروتوكولات يقودها أطباء، شهادات دولية، والتزام بسلامة الضيوف في بانكوك.

ISO 9001:2015 Certified Partner Labs
GMP Compliant Partner Laboratory
Thai Medical Council Registered
International Guest Safety Standards

Mounjaro vs Wegovy vs Retatrutide

A factual comparison of mechanism, status and administration. Individual response varies; all three require physician supervision.

FeatureMounjaroWegovyRetatrutide
MoleculeTirzepatideSemaglutideRetatrutide
Receptor targetsGIP + GLP-1 (dual)GLP-1 onlyGIP + GLP-1 + glucagon (triple)
Injection frequencyOnce weeklyOnce weeklyOnce weekly
Regulatory statusFDA approved (T2D, weight)FDA approved (weight)Investigational (Phase III)
ManufacturerEli LillyNovo NordiskEli Lilly
At Healthi LifeFrom ฿12,000 / vialOn requestFrom ฿10,000 / vial

⚕️ Prescription-only medicines. Initiated and supervised by a licensed physician at Healthi Life Ekkamai.

البرامج

اختر برنامجك

Wegovy Program

On request

  • Semaglutide 2.4 mg weekly
  • Physician consultation
  • Biomarker review
  • Injection training
اختر البرنامج
موصى به

Mounjaro Program

From ฿12,000

  • Tirzepatide 2.5–10 mg weekly
  • Physician consultation
  • Biomarker review
  • Injection training
اختر البرنامج

Retatrutide Program

From ฿10,000

  • Investigational triple agonist
  • Research-use informed consent
  • Extended biomarker panel
  • Monthly follow-up
اختر البرنامج
الأسئلة الشائعة

الأسئلة المتكررة

A physician-supervised program combining medical intake, contraindication screening, baseline biomarkers, a prescribed GLP-1 medication (Mounjaro, Wegovy or Retatrutide) and monthly follow-up. It is doctor-led, not a cosmetic or over-the-counter service.

There is no single best option. Mounjaro is a dual GIP/GLP-1 agonist approved for type 2 diabetes and weight management. Wegovy is a GLP-1 agonist approved for weight management. Retatrutide is investigational. The physician selects based on indications, contraindications and biomarker profile.

No. Retatrutide is an investigational triple agonist (Phase III) and is not authorised in the European Union, so it is neither sold nor prescribed in European pharmacies. At Healthi Life Ekkamai in Bangkok it is administered only under physician supervision in a research framework, with informed consent, from ฿10,000 per vial. Products sold online without a prescription carry no quality guarantee and are never recommended.

Mounjaro and Wegovy are prescription medicines and must be initiated by a licensed physician. Retatrutide is investigational and is offered only under physician supervision in a research framework. They cannot be sold over the counter.

Most guests follow a 3 to 12 month physician-supervised program, with monthly follow-up. Duration is individualized based on clinical goals, tolerability, biomarker trends and the broader longevity plan.

The most reported effects are nausea, diarrhea, decreased appetite, vomiting and constipation, typically during titration. Rare but serious risks include pancreatitis and gallbladder disease. Every program includes monthly side-effect review.

Yes. HbA1c, lipid panel, hepatic and renal function are established before the first dose. For Retatrutide, an extended panel is added. Follow-up labs are reviewed at every monthly visit.

Yes. GLP-1 medicines such as Mounjaro and Wegovy are legal in Thailand when prescribed by a licensed physician, with no residency or long-term visa required. Expats and short-stay visitors are equally welcome at Healthi Life Ekkamai — your program starts with an in-clinic physician consultation and baseline labs, and monthly follow-up can continue by telemedicine once you have travelled home, so dosing stays monitored.

GLP-1 medicines are temperature-sensitive and must be kept cold. After in-clinic injection training, your physician advises on safe cold-chain transport, self-injection and titration for the weeks between visits. Retatrutide, being investigational, is administered within a supervised research framework and is not dispensed for unsupervised long-term travel.

ماذا تقول الأبحاث

تستند الإدارة الطبية للوزن بمحفّزات مستقبلات GIP/GLP-1 إلى تجارب المرحلة الثالثة العشوائية المحكومة بغفل. فيما يلي تلك النتائج، مع ذكر الرقم المقيس لكل دراسة.

  1. في تجربة عشوائية محكومة بغفل استمرت 72 أسبوعاً وشملت 2539 بالغاً، بلغ متوسط تغير وزن الجسم −16.0% عند 5 ملغ، و−21.4% عند 10 ملغ، و−22.5% عند 15 ملغ، مقابل −2.4% في مجموعة الغفل.

    Tirzepatide Once Weekly for the Treatment of ObesityNew England Journal of Medicine, 2022

  2. بالمتابعة حتى 176 أسبوعاً، تطوّر 1.3% من المشاركين المعالَجين المصابين بالسمنة وما قبل السكري إلى داء السكري من النوع الثاني مقابل 13.3% في مجموعة الغفل (نسبة الخطر 0.07، P < 0.001). وبلغ متوسط تغير الوزن −19.7% عند 15 ملغ مقابل −1.3% في مجموعة الغفل.

    Tirzepatide for Obesity Treatment and Diabetes PreventionNew England Journal of Medicine, 2024

  3. مراجعة منهجية وتحليل تلوي محدّثان يجمعان تجارب تيرزيباتيد الأسبوعية مقابل الغفل، بما فيها SURMOUNT-2، ويؤكدان أثر إدارة الوزن في مجموع المشاركين.

    Efficacy and safety of once-weekly tirzepatide for weight management compared to placebo: an updated systematic review and meta-analysis including the latest SURMOUNT-2 trialSystematic review and meta-analysis, 2024

تصف هذه الدراسات نتائج لوحظت لدى المشاركين فيها. وهي ليست تنبؤاً بنتيجتك ولا تشكل أي ضمان لنتيجة العلاج. لا يُقدَّم العلاج بالخلايا الجذعية في Healthi Life إلا بعد استشارة طبية وتقييم فردي.

Medically reviewed by Dr. Petch & Dr. First

Dr. Petch — International Board of Lifestyle Medicine (IBLM) — Diplomate

Dr. First — Dermatologist & Peptides Specialist

Last reviewed: July 1, 2026

هذه الصفحة للمعلومات العامة فقط ولا تُعد استشارة طبية أو تشخيصاً أو علاجاً. تختلف النتائج من شخص لآخر. ⁨Mounjaro, Wegovy — tirzepatide, semaglutide⁩ دواء يُصرف بوصفة طبية، ولا يُصرف أو يُعطى إلا بعد تقييم من طبيب مرخَّص. هذه الصفحة معلومات طبية، وليست إعلاناً ولا عرضاً للعلاج. استشر دائماً طبيباً مؤهلاً بشأن حالتك. اطّلع على إخلاء المسؤولية الطبية الكامل.

Book a Medical Weight Loss Consultation

Speak with a physician at Healthi Life Ekkamai for eligibility review, baseline biomarkers and the GLP-1 molecule best suited to your profile.

الموقع

94 Ekkamai 10 Alley, Khlong Tan Nuea, Watthana, Bangkok 10110

5 min by taxi from BTS Ekkamai

ساعات العمل

Mon-Sat: 11:00 AM – 7:00 PM

وقت الاستجابة: أقل من ساعتين